Late-Breaking Abstracts

Key Dates
Abstract submission opens
February 5, 2018
Abstract submission deadline
March 23, 2018, 11:59 p.m. EST
Notification to authors April 2 to 6, 2018
Abstract presenter registration deadline April 20, 2018


Late-breaking abstracts should describe the latest advances that will change our daily clinical practice, and should highlight novel and practice-changing studies. The selection process will favour abstracts with ground-breaking and unique data that would not otherwise have been presented at the Congress.

The following are some examples of suitable late-breaking abstracts:

  • The results of a practice-changing prospective Phase III clinical trial
  • A Phase II study showing in a novel context
  • An early clinical trial with novel proof-of-principle data

In every case, the results should not have been fully available by the regular abstract submission deadline.
Please ensure you have read the abstract submission guidelines prior to submitting your Late-Breaking Abstract.

Abstract Public Release (Embargo) Dates and Times

Late-breaking abstracts (LBAs) will be publicly released throughout the WFH 2018 World Congress. The complete embargo dates and public release schedule for LBAs is detailed below.

Abstract type
Embargo Lift Date and Time
Regular Published abstract
9:00 a.m. EST on May 10, 2018
Late-Breaking Abstracts presented in a free paper session
             Monday, May 21, 2018    7:00 a.m. WE on May 21, 2018
             Tuesday, May 22, 2018 7:00 a.m. WE on May 22, 2018
             Wednesday, May 23, 2018 7:00 a.m. WE on May 23, 2018




The WFH 2018 World Congress is supported by the Glasgow City
Council and VisitScotland

Submit your abstract

© World Federation of Hemophilia